Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Wondering what age to start retirement planning? The earlier you begin, the better prepared you'll be for a comfortable retirement.
25,085 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
AMD has delivered a dramatic rally this year, but the big question remains: is the move sustainable? This article bre...
If SpaceX eyes an IPO, the idea of a space-faring civilization could reshape how investors evaluate growth and risk. ...
A quantum computing stock has tumbled roughly 40% from its peak. This article weighs the risks and potential rewards,...
Alphatec (ATEC) is navigating a shifting spine device market. This guide breaks down expected 2025 earnings, key driv...
Adecoagro (AGRO) investors eye the 2025 earnings path as commodity markets, currency volatility, and crop yields shap...
Investing in cosmetics often blends branding bias with numbers. This guide looks at whether e.l.f. beauty stock rhode...
Thursday brought a notable move for AMD as shares jumped on favorable analyst commentary and a rising server CPU TAM ...
As energy prices swing, investors ask which Vanguard ETF can best capture opportunity while managing risk. This guide...
As institutional buyers step into Openlane, individual investors gain a front-row seat to a digitized used-vehicle ma...
Oracle isn't done spending on AI, and the move is shaking up how investors view cloud growth and profitability. This ...
If SpaceX ever hits the public markets, the big question isn’t rocket tech or Starlink alone. It’s whether the compan...